Hydroxyurea-induced leg ulceration in 14 patients

Annals of Internal Medicine

Volumn 128, Issue 1, 1998, Pages 29-32

  Best, Patricia J ^a   Daoud, Mazen S ^a   Pittelkow, Mark R ^a   Petitt, Robert M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANAGRELIDE; ANTIBIOTIC AGENT; HYDROXYUREA; PENTOXIFYLLINE; PREDNISONE; WARFARIN;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DOSE RESPONSE; DRUG ERUPTION; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; LEG ULCER; MALE; MOUTH ULCER; PATHOPHYSIOLOGY; PHOTOSENSITIZATION; PRIORITY JOURNAL; STOMATITIS; TREATMENT INDICATION; ULCER HEALING;

EID: 0031974586     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-128-1-199801010-00005     Document Type: Article

References (12)

1. Stock CC, Clarke DA, Philips FS, Barclay RK. Sarcoma 180 screening data. Cancer Res. 1960;20(Pt 2):193-381.
2. Donehower RC. An overview of the clinical experience with hydroxyurea. Semin Oncol. 1992;19(3 Suppl 9):11-9.
3. Kinsella TJ. Radiosensitization and cell kinetics: clinical implications for Sphase-specific radiosensitizers. Semin Oncol. 1992;19(3 Suppl 9):41-7.
4. Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med. 1993;328:73-80.
5. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317-22.
6. Lori F, Malykh A, Cara A, Sun D, Weinstein JN, Lisziewicz J, et al. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science. 1994;266:801-5.
7. Daoud MS, Gibson LE, Pittelkow MR. Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea. J Am Acad Dermatol. 1997;36:178-82.
8. Montefusco E, Alimena G, Gastaldi R, Carlesimo OA, Valesini G, Mandelli F. Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia. Tumori. 1986;72:317-21.
9. Boyd AS, Neldner KH. Hydroxyurea therapy. J Am Acad Dermatol. 1991; 25:518-24.
10. Nguyen TV, Margolis DJ. Hydroxyurea and lower leg ulcers. Cutis. 1993; 52:217-9.
11. Yarbro JW. Mechanism of action of hydroxyurea. Semin Oncol. 1992;19(3 Suppl 9):1-10.
12. Fitzpatrick JE. The cutaneous histopathology of chemotherapeutic reactions. J Cutan Pathol. 1993;20:1-14.